The Centers for Disease Control and Prevention estimates that gum disease has cost the United States nearly $50 billion over the last 15 years, with a whopping $10 billion spent on treatments in 2016 alone.
The CDC says that, by 2020, $20 billion of that will be spent on drugs, but that many of these drugs are ineffective.
“We’re talking about millions of dollars of medical treatment,” said Dr. Jeffrey Gersh, the director of the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the CDC.
“And if we didn’t do that, we would have no gum disease.”
Gums are a unique immune system.
They have a hard time rejecting foreign invaders, so they can’t tolerate the same bacteria or viruses that can affect the human body.
The bacteria that cause the disease cause the outer layer of the lining of the mouth to break down.
The outer layer begins to crumble.
In the case of gum disease, this breakdown leads to the gum lining to harden, and the bacteria can grow inside.
In this way, they can become resistant to treatment.
The bacteria can then multiply, increasing the size of the outer lining, which eventually results in gum disease.
And if untreated, this can lead to permanent scarring, which can lead eventually to gum cancer.
The NIAID estimates that more than a quarter of all people who have gum disease have at least one other infection.
Some infections are treatable with antibiotics, while others are not.
In fact, more than one in five people with gum cancer have a non-serious infection.
Gum disease has become a major issue in recent years.
The number of people in the United Kingdom with gum disorder increased by 1.4 million between 2013 and 2017.
The disease is also spreading around the world, with cases reported in more than 20 countries, including the United Arab Emirates, Spain, Germany, Denmark, New Zealand, Japan, Portugal, South Africa, and Canada.
In the United State, the number of new cases of gum cancer rose by 1 percent between 2016 and 2017, and has more than doubled since 2015.
While gum disease can cause symptoms that include a dry mouth and tongue, it can also cause more serious problems, such as pneumonia, stroke, and even death.
For some, the medical treatment for gum disease is often a combination of antibiotics and other therapies.
But others will have to be more selective.
In 2018, researchers at Johns Hopkins University and University of Maryland found that the combination of anti-bacterial medications, anti-inflammatory medications, and anti-fungal medications were the most effective treatments for treating people with oral cancer.
This new treatment may also be effective in people who suffer from other types of cancer, such from lung, pancreas, breast, and skin cancer.
Dr. Matthew Meehan, a senior fellow at Johns, said the treatment will help patients with these conditions live longer and healthier lives.
“If there are other treatments out there, like immunosuppressive drugs or surgery, I think this would be an appropriate treatment,” Meehan said.
“I think it will help a lot of people,” said Mark Luskin, chief of oral health services at Johns.
“There are lots of things that we don’t know about this.
It’s not known how this disease works, and we don, so I think we need to do a lot more research to understand this better.”
The new treatment comes at a time when doctors and scientists are struggling to find effective ways to treat gum disease with medications.
Many researchers have used drugs like ibuprofen and naproxen, which are commonly prescribed for ulcerative colitis and other chronic diseases, but these drugs can cause side effects.
The new study, published in the journal Gastroenterology, used two different treatments that worked in different ways.
One of the drugs, called Rituximab, is an immune suppressor.
The other drug, Nivolumab, also known as Nexium, was developed as a treatment for psoriasis, but is more commonly used to treat psorias and other skin conditions.
Both treatments have been shown to have an effect in reducing gum disease in animals, and researchers are now studying whether they work for other types and types of cancers.
Dr. David J. Siegel, a professor at the University of California San Francisco and a member of the NIAIDS, said he’s hopeful that gum medication therapy will help with this.
“The question is, are there people who are more susceptible to these side effects?” he said.
“It is something we need more research on.”
Dr. Sollmer said the research he and other researchers are conducting is aimed at developing better therapies for gum diseases.
He added that he hopes to see a significant decrease in the number and type of people who get gum disease before the disease gets so severe that they need